The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

From unexpected gender disparities to alarming teen statistics, discover essential facts about opioid medications that every ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

Vertex Pharmaceuticals ( VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Shares of Vertex Pharmaceuticals rose 8% in off-hours trading after the pharmaceutical company won U.S. approval for the [first new non-opioid painkiller in decades]( ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...